Global Effort Intensifies to Eliminate Hepatitis by 2030
Seoul, South Korea – September 13, 2024 – A concerted international strategy to combat hepatitis and achieve its elimination by 2030 is gaining momentum, with South Korea playing a key role.The initiative focuses on prevention, diagnosis, and treatment of viral hepatitis – encompassing types A, B, and C – aiming to reduce new infections and mortality rates worldwide. Approximately 500 million people globally live with chronic hepatitis, a leading cause of liver disease and cancer.
The escalating global hepatitis crisis demands urgent action. Viral hepatitis affects individuals of all ages and socioeconomic backgrounds, disproportionately impacting vulnerable populations. Without widespread intervention, the number of hepatitis-related deaths is projected to rise considerably, straining healthcare systems and hindering global health security. The 2030 goal represents a critical turning point, requiring sustained commitment and collaborative efforts from governments, healthcare organizations, and international partners.
South Korea is actively contributing to this global effort through comprehensive national programs focused on hepatitis prevention, early detection, and treatment access. These programs include widespread vaccination campaigns for hepatitis A and B, enhanced screening initiatives to identify individuals with chronic hepatitis B and C, and expanded access to antiviral therapies. The nation is also investing in research to develop innovative diagnostic tools and treatment strategies.
The strategy emphasizes a multi-pronged approach, encompassing strengthened surveillance systems, improved data collection, and enhanced public awareness campaigns. International collaboration is central, with organizations like the world Health association (WHO) coordinating efforts and providing technical assistance to countries worldwide. Successful implementation hinges on increased funding, equitable access to healthcare, and a commitment to addressing the social determinants of health that contribute to hepatitis transmission.
